Finally it should be noted that screens for promoter methylation in a variety of other cancers (including breast and ovarian) have revealed no significant or consistent methylation of the Bim promoter using the same MSP primer sets as those used in this study (PS – unpublished data). Here, BCL2L11 is linked to cancer.